Location: Dallas, TX
CIK: 0001617201 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value: $187M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | 321,093 | $19.47M | 10.4% | $26.31 | +20.1% | SHS | G72800108 |
| — | HORIZON THERAPEUTICS PUB L | 303,000 | $18.75M | 10.0% | $61.89 | — | SHS | G46188101 |
| GLPG | GALAPAGOS NV | 405,000 | $17.27M | 9.3% | $57.13 | — | SPON ADR | 36315X101 |
| — | KEZAR LIFE SCIENCES INC | 1,327,899 | $11.43M | 6.1% | $7.73 | — | COM | 49372L100 |
| ALKS | ALKERMES PLC | 502,150 | $11.21M | 6.0% | $26.01 | 0.0% | SHS | G01767105 |
| — | ALBIREO PHARMA INC | 491,244 | $9.51M | 5.1% | $30.05 | — | COM | 01345P106 |
| MGTX | MEIRAGTX HLDGS PLC | 1,103,365 | $9.279M | 5.0% | $11.57 | -23.8% | COM | G59665102 |
| KALV | KALVISTA PHARMACEUTICALS INC | 530,062 | $7.691M | 4.1% | $16.87 | -17.1% | COM | 483497103 |
| CRL | CHARLES RIV LABS INTL INC | 33,220 | $6.538M | 3.5% | $325.04 | -33.6% | COM | 159864107 |
| ALDX | ALDEYRA THERAPEUTICS INC | 1,210,800 | $6.466M | 3.5% | $6.08 | -1.3% | COM | 01438T106 |
| HUM | HUMANA INC | 12,800 | $6.21M | 3.3% | $469.33 | 0.0% | COM | 444859102 |
| MIRM | MIRUM PHARMACEUTICALS INC | 285,000 | $5.988M | 3.2% | $22.97 | +4.8% | COM | 604749101 |
| THC | TENET HEALTHCARE CORP | 102,000 | $5.261M | 2.8% | $64.44 | -7.9% | COM NEW | 88033G407 |
| JNJ | JOHNSON & JOHNSON | 31,704 | $5.179M | 2.8% | $152.90 | 0.0% | COM | 478160104 |
| QDEL | QUIDELORTHO CORP | 62,900 | $4.496M | 2.4% | $98.71 | -9.4% | COM | 219798105 |
| CUE | CUE BIOPHARMA INC | 1,545,573 | $3.447M | 1.8% | $10.87 | -73.6% | COM | 22978P106 |
| — | PROTHENA CORP PLC | 53,100 | $3.219M | 1.7% | — | — | Call | G72800908 |
| RCKT | ROCKET PHARMACEUTICALS INC | 200,000 | $3.192M | 1.7% | $20.50 | -23.9% | COM | 77313F106 |
| STTK | SHATTUCK LABS INC | 1,120,776 | $3.026M | 1.6% | $8.13 | -53.8% | COM | 82024L103 |
| ORIC | ORIC PHARMACEUTICALS INC | 936,334 | $2.996M | 1.6% | $4.00 | 0.0% | COM | 68622P109 |
| INCY | INCYTE CORP | 40,450 | $2.696M | 1.4% | $73.88 | 0.0% | COM | 45337C102 |
| OMCL | OMNICELL COM | 30,700 | $2.672M | 1.4% | $105.05 | 0.0% | COM | 68213N109 |
| AVTR | AVANTOR INC | 122,668 | $2.404M | 1.3% | $26.79 | 0.0% | COM | 05352A100 |
| BAX | BAXTER INTL INC | 39,000 | $2.101M | 1.1% | $55.31 | 0.0% | COM | 071813109 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 80,000 | $1.96M | 1.1% | $18.60 | 0.0% | COM | 76243J105 |
| — | 1LIFE HEALTHCARE INC | 106,200 | $1.821M | 1.0% | $7.84 | — | COM | 68269G107 |
| — | CASSAVA SCIENCES INC | 35,900 | $1.501M | 0.8% | — | — | Put | 14817C957 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 113,800 | $1.434M | 0.8% | $10.32 | +24.8% | COM | 09058V103 |
| ARDX | ARDELYX INC | 1,126,127 | $1.34M | 0.7% | $0.74 | +29.2% | COM | 039697107 |
| EOLS | EVOLUS INC | 160,200 | $1.29M | 0.7% | $10.60 | 0.0% | COM | 30052C107 |
| PRQR | PROQR THRAPEUTICS N V | 1,716,290 | $1.277M | 0.7% | $2.05 | -60.9% | SHS EURO | N71542109 |
| ADCT | ADC THERAPEUTICS SA | 247,630 | $1.194M | 0.6% | $7.24 | 0.0% | SHS | H0036K147 |
| — | GRAPHITE BIO INC | 356,445 | $1.13M | 0.6% | $3.17 | — | COM | 38870X104 |
| SPRY | SILVERBACK THERAPEUTICS INC | 196,257 | $1.036M | 0.6% | $4.91 | +0.4% | COM | 82835W108 |
| ABCL | ABCELLERA BIOLOGICS INC | 86,504 | $856K | 0.5% | $10.97 | 0.0% | COM | 00288U106 |
| — | R1 RCM INC | 32,113 | $595K | 0.3% | $18.53 | — | COM | 77634L105 |
| SPOK | SPOK HLDGS INC | 65,000 | $497K | 0.3% | $6.94 | 0.0% | COM | 84863T106 |
| MRVI | MARAVAI LIFESCIENCES HLDGS I | 8,540 | $218K | 0.1% | $25.09 | 0.0% | COM CL A | 56600D107 |